文献速递认知障碍与谵妄老年综合评估

人形陪伴机器人对长期照护机构痴呆居民症状及照护者困扰的影响

Effects of a Humanoid Companion Robot on Dementia Symptoms and Caregiver Distress for Residents in Long-Term Care.
PubMed 文献 · J Am Med Dir Assoc · 2020-07-23

一项在香港7家长期照护机构开展的32周双组随机对照试验,纳入103名痴呆居民。结果显示,人形陪伴机器人Kabochan在干预8周后可能短期改善神经精神症状相关照护者困扰(交互效应显著,中等效应量),撤除后症状加重;其他健康结局无组间差异。

要点

  • Kabochan干预8周后,神经精神相关照护者困扰出现显著组×时间交互效应,效应量中等。
  • 撤除机器人后第24周干预组神经精神症状较前加重,效应量小到中等。
  • 其他健康结局(认知、日常生活活动、生活质量、抑郁)未见组间统计学差异。

核心结论

  • Kabochan人形陪伴机器人可能短期减少痴呆居民的神经精神症状及照护者相关困扰。

研究设计与样本

  • 2臂随机对照试验,采用ABAB撤除设计,持续32周,基线8周后干预8周、撤除8周、再干预8周。
  • 纳入香港7家长期照护机构的103名痴呆居民(干预组52人,对照组51人;76%为女性,年龄87.2±7.4岁)。

主要发现

  • 第16周神经精神相关照护者困扰的组×时间交互效应显著(F=6.72,P=.011,ηp2=0.06)。
  • 撤除阶段第24周干预组神经精神症状加重(F=4.68,P=.003,ηp2=0.04)。
  • 其他健康结局未见组间统计学差异。

关键数值与推荐

  • 主要结局采用神经精神量表问卷(症状严重度和照护者困扰子量表)及老年抑郁量表评估。
  • 次要结局采用香港蒙特利尔认知评估5分钟方案、改良Barthel指数、阿尔茨海默病生活质量量表评估。

临床怎么用

  • 可将人形陪伴机器人作为短期辅助手段,用于减少痴呆居民神经精神症状及照护者困扰。
  • 将机器人纳入常规痴呆照护时,需制定个体化照护计划并持续监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To test the effects of deploying a humanoid companion robot (Kabochan) in comparison with usual care for long-term care facilities' residents with dementia. DESIGN: A 2-arm, randomized controlled trial with ABAB withdrawal design, lasting 32 weeks. After an 8-week baseline period, Kabochan was introduced in a nonfacilitated, individual approach with experimental-group participants (n = 52) for 8 weeks, then removed for 8 weeks, and then reintroduced for another 8 weeks. The control group (n = 51) received the usual standardized care. SETTING AND PARTICIPANTS: Seven long-term care facilities in Hong Kong. 103 residents (76% women, 87.2 ± 7.4 years) with a clinical diagnosis of dementia. MEASURES: Outcome assessments occurred at 5 time points: baseline (week 1) and the end of each phase (weeks 8, 16, 24, and 32). Primary outcomes were assessed with the Neuropsychiatric Inventory Questionnaire (symptom severity and caregiver distress subscales) and the Geriatric Depression Scale; secondary outcomes were measured by the Hong Kong Montreal Cognitive Assessment 5-minute Protocol, the Modified Barthel Index for Activities of Daily Living, and the Quality of Life-Alzheimer's disease scale. RESULTS: A multivariate analysis of variance indicated a statistically significant group × time interaction for neuropsychiatric-related caregiver distress at week 16 (F = 6.72, P = .011), with a moderate effect size (ηp2 = 0.06). When Kabochan was removed in the withdrawal phase (weeks 17-24), the neuropsychiatric symptoms became more severe at week 24 for the intervention group (F = 4.68, P = .003), although the effect size was small to moderate (ηp2 = 0.04). No statistical between-group differences were found in other health outcomes. CONCLUSIONS AND IMPLICATIONS: The Kabochan was potentially effective at reducing short-term neuropsychiatric symptoms and relevant caregiver distress for residents with dementia. An individualized care plan with continuous monitoring is required to integrate the humanoid robot into routine dementia care.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Chen K, Lou VW, Tan KC, et al. Effects of a Humanoid Companion Robot on Dementia Symptoms and Caregiver Distress for Residents in Long-Term Care. J Am Med Dir Assoc. 2020. PMID: 32713772. doi:10.1016/j.jamda.2020.05.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。